Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07313969Completed
Randomised, single-blind trial of sevoflurane (2 arms), sponsored by Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Primary endpoint: Total sevoflurane consumption. Started Dec 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07313969.